The FDA has approved an oral, small molecule MEK inhibitor for adult and pediatric patients 2 years of age and older with ...
News Medical on MSN7d
Type 1 diabetes patients face lower cardiovascular risk than Type 2 diabetesA new study published in JSCAI has revealed a lower risk of cardiovascular events for patients with Type 1 diabetes (often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback